Bob Li
Overview
Explore the profile of Bob Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu S, Doshi S, Ebstein A, Holland J, Sapir A, Leung M, et al.
JCO Clin Cancer Inform
. 2024 Nov;
8:e2400182.
PMID: 39565969
Purpose: Pulse oximetry remote patient monitoring (RPM) post-hospital discharge increased during the COVID-19 pandemic as patients and providers sought to limit in-person encounters and provide more care in the home....
2.
Mondaca S, Walch H, Sepulveda S, Schultz N, Munoz G, Yaqubie A, et al.
JCO Glob Oncol
. 2024 Oct;
10:e2400090.
PMID: 39388662
Purpose: Gallbladder cancer (GBC) is a biliary tract malignancy characterized by its high lethality. Although the incidence of GBC is low in most countries, specific areas such as Chile display...
3.
Hickman R, Miller A, Holle B, Jee J, Liu S, Ross D, et al.
Acta Neuropathol Commun
. 2024 Sep;
12(1):151.
PMID: 39289779
The characterization of genetic alterations in tumor samples has become standard practice for many human cancers to achieve more precise disease classification and guide the selection of targeted therapies. Cerebrospinal...
4.
Choudhury N, Lai W, Makhnin A, Heller G, Eng J, Li B, et al.
Clin Cancer Res
. 2024 Jun;
30(17):3697-3703.
PMID: 38940666
Purpose: Recurrent small-cell lung cancer (SCLC) has few effective treatments. The EZH2-SLFN11 pathway is a driver of acquired chemoresistance that may be targeted. Patients And Methods: This phase I/II trial...
5.
Tringale K, Skakodub A, Egger J, Eichholz J, Yu Y, Gomez D, et al.
JCO Precis Oncol
. 2024 May;
8:e2300470.
PMID: 38691815
Purpose: Small cell lung cancer (SCLC) often metastasizes to the brain and has poor prognosis. SCLC subtypes distinguished by expressing transcriptional factors ASCL1 or NEUROD1 have been identified. This study...
6.
Dee E, Swami N, Kazzi B, Lapen K, Franco I, Jain B, et al.
JCO Oncol Pract
. 2024 Jan;
20(4):525-537.
PMID: 38252900
Purpose: Hispanic and Latinx people in the United States are the fastest-growing ethnic group. However, previous studies in non-small-cell lung cancer (NSCLC) often analyze these diverse communities in aggregate. We...
7.
Drilon A, Lin J, Filleron T, Ni A, Milia J, Bergagnini I, et al.
J Thorac Oncol
. 2018 Jul;
13(10):1595-1601.
PMID: 30017832
Introduction: In ret proto-oncogene (RET)-rearranged lung cancers, data on the frequency of brain metastases and, in particular, the outcomes of multikinase inhibitor therapy in patients with intracranial disease are not...
8.
Brierley J, Srigley J, Yurcan M, Li B, Rahal R, Ross J, et al.
Healthc Q
. 2013 Sep;
16(3):27-33.
PMID: 24034774
The stage of a patient's cancer at diagnosis is essential to predict the prognosis and plan the treatment. Since 2008, stage data have been collected on all Ontario patients with...